February 5th, 2014
Eric Topol to Be AT&T’s Chief Medical Advisor
Larry Husten, PHD
AT&T announced today that it has appointed cardiologist Eric Topol as its Chief Medical Advisor. The company said he will “impact the design, development and delivery of AT&T’s healthcare IT solutions, connecting the healthcare ecosystem to enhance health outcomes and care delivery processes for patients and their caregivers.” In addition to his duties at AT&T, Topol will continue to serve as the the […]
August 24th, 2012
Topol: The Clinical Trial World Is “Contrived”
Harlan M. Krumholz, MD, SM
Eric Topol says it’s time to “get rid of the randomized trial.” What do you say?
NEJM Journal Watch — Recent Cardiology Articles- Extensive Ablation vs. Pulmonary Vein Isolation in Persistent Atrial Fibrillation
- Can a Novel Stent Design Improve Long-Term Outcomes of Percutaneous Coronary Intervention?
- Are Angiographically-Derived Coronary Physiology Measurements Ready for Use in the Cath Lab?
- A Randomized Trial of Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation
- An Early Look at a Novel Intranasal Loop Diuretic